An Adaptive Study of the Pharmacokinetics of Favipiravir in Patients With Severe Influenza.
Phase of Trial: Phase II
Latest Information Update: 19 Apr 2018
At a glance
- Drugs Favipiravir (Primary) ; Oseltamivir
- Indications Influenza virus infections
- Focus Pharmacokinetics
- 27 Feb 2018 Status changed from not yet recruiting to recruiting.
- 12 Jan 2018 New trial record